Abstract
We report here the identification of α1 Na/K-ATPase as a major regulator of the proto-oncogene Src kinase and the role of this regulation in control of Warburg effect and tumor growth. Specifically, we discovered Y260 in α1 Na/K-ATPase as a Src-specific phosphorylation and binding site and that Y260 phosphorylation is required for Src-mediated signal transduction in response to a number of stimuli including EGF. As such, it enables a dynamic control of aerobic glycolysis. However, such regulation appears to be lost or attenuated in human cancers as the expression of Na/K-ATPase α1 was significantly decreased in prostate, breast and kidney cancers, and further reduced in corresponding metastatic lesions in patient samples. Consistently, knockdown of α1 Na/K-ATPase led to a further increase in lactate production and the growth of tumor xenograft. These findings suggest that α1 Na/K-ATPase works as a tumor suppressor and that a loss of Na/K-ATPase-mediated Src regulation may lead to Warburg phenotype in cancer.
Document Type
Article
Publication Date
8-17-2018
Digital Object Identifier (DOI)
https://doi.org/10.1038/s41598-018-29995-2
Funding Information
The studies were conducted with support provided by the Biostatistics and Bioinformatics Shared Resource Facilities of the University of Kentucky Markey Cancer Center (P30CA177558). This work was supported by NIH grant HL-109015 from NHLBI.
Related Content
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-018-29995-2.
Repository Citation
Banerjee, Moumita; Cui, Xiaoyu; Li, Zhichuan; Yu, Hui; Cai, Liquan; Jia, Xuelian; He, Daheng; Wang, Chi; Gao, Tianyan; and Xie, Zijian, "Na/K-ATPase Y260 Phosphorylation-Mediated Src Regulation in Control of Aerobic Glycolysis and Tumor Growth" (2018). Markey Cancer Center Faculty Publications. 126.
https://uknowledge.uky.edu/markey_facpub/126
Supplementary Data
Notes/Citation Information
Published in Scientific Reports, v. 8, article no. 12322, p. 1-13.
© The Author(s) 2018
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.